About 410 Medical
410 Medical is a company based in Durham (United States) founded in 2012 by Mark Piehl.. 410 Medical has raised $65.98 million across 12 funding rounds from investors including WakeMed, WellStar and Orlando Health. 410 Medical operates in a competitive market with competitors including Hospira, Ivenix, IRadimed, Belmont Medical Technologies and Linear Health Sciences, among others.
- Headquarter Durham, United States
- Founders Mark Piehl
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.98 M (USD)
in 12 rounds
-
Latest Funding Round
$14 M (USD), Series B
Mar 17, 2025
-
Investors
WakeMed
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
3 people
Office Team
1 people
Software Development Team
1 people
Operations Team
1 people
Unlock access to complete
Funding Insights of 410 Medical
410 Medical has successfully raised a total of $65.98M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $14 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series B — $14.0M
-
First Round
First Round
(13 Jan 2015)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series B - 410 Medical | Valuation | Hatteras Venture Partners | |
| May, 2023 | Amount | Series B - 410 Medical | Valuation | Hatteras Venture Partners | |
| Oct, 2022 | Amount | Series B - 410 Medical | Valuation | Hatteras Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 410 Medical
410 Medical has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include WakeMed, WellStar and Orlando Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location | |
|
Ballad Ventures is focused on healthcare innovation investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 410 Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 410 Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
410 Medical Comparisons
Competitors of 410 Medical
410 Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hospira, Ivenix, IRadimed, Belmont Medical Technologies and Linear Health Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Infusion management systems are developed with wireless web-based architecture.
|
|
| domain | founded_year | HQ Location |
Developer of IV Infusion system and patient monitoring systems for the MRI setting
|
|
| domain | founded_year | HQ Location |
Fluid management and critical care medical devices are developed.
|
|
| domain | founded_year | HQ Location |
IV breakaway valves are provided to prevent medical tubing dislodgement.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 410 Medical
When was 410 Medical founded?
410 Medical was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is 410 Medical located?
410 Medical is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is 410 Medical a funded company?
410 Medical is a funded company, having raised a total of $65.98M across 12 funding rounds to date. The company's 1st funding round was a Series B of $25.69M, raised on Jan 13, 2015.
What does 410 Medical do?
410 Medical was founded in 2012 and is based in Durham, United States. Operations are focused on the medical devices sector, where systems for rapid fluid infusion are supplied to support care for critically ill patients. The LifeFlow Fluid Infuser is offered as a key product, enabling healthcare providers to administer fluids at controlled rates during emergencies.
Who are the top competitors of 410 Medical?
410 Medical's top competitors include IRadimed, Belmont Medical Technologies and Hospira.
Who are 410 Medical's investors?
410 Medical has 17 investors. Key investors include WakeMed, WellStar, Orlando Health, Sarnova, and OSF HealthCare.